Abstract
Hydroxyurea is an antineoplastic drug, which is also widely used in the treatment of sickle cell disease. Various methods including colorimetry, high performance liquid chromatography, and gas chromatography-mass spectrometry (GC-MS) are available for the assay of hydroxyurea. In the gas chromatography method described, the drug is extracted from serum, plasma, or urine using ethyl acetate and phosphate buffer (pH 6). The organic phase containing drug is separated and dried under a stream of nitrogen. After trimethylsilyl derivatization, samples are analyzed using GC-MS. Quantitation of the drug in a sample is achieved by comparing responses of the unknown sample to the responses of the calibrators using selected ion monitoring. Tropic acid is used as an internal standard.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bachir, D., Hulin, A., Huet, E., Habibi, A., Nzouakou, R., El Mahrab, M., Astier, A. and Galacteros, F. (2007) Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease. Hemoglobin, 31, 417–25.
Ferguson, R.P., Arun, A., Carter, C., Walker, S.D. and Castro, O. (2002) Hydroxyurea treatment of sickle cell anemia in hospital-based practices. Am J Hematol, 70, 326–8.
Platt, O.S. (2008) Hydroxyurea for the treatment of sickle cell anemia. N Engl J Med, 358, 1362–9.
Svarch, E., Machin, S., Nieves, R.M., Mancia de Reyes, A.G., Navarrete, M. and Rodriguez, H. (2006) Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries. Pediatr Blood Cancer, 47, 111–2.
Cokic, V.P., Smith, R.D., Beleslin-Cokic, B.B., Njoroge, J.M., Miller, J.L., Gladwin, M.T. and Schechter, A.N. (2003) Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest, 111, 231–9.
Ferster, A., Vermylen, C., Cornu, G., Buyse, M., Corazza, F., Devalck, C., Fondu, P., Toppet, M. and Sariban, E. (1996) Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood, 88, 1960–4.
Bolton, B.H., Woods, L.A., Kaung, D.T. and Lawton, R.L. (1965) A simple method of colorimetric analysis for hydroxyurea (Nsc-32065). Cancer Chemother Rep, 46, 1–5.
Manouilov, K.K., McGuire, T.R. and Gwilt, P.R. (1998) Colorimetric determination of hydroxyurea in human serum using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 708, 321–4.
Pujari, M.P., Barrientos, A., Muggia, F.M. and Koda, R.T. (1997) Determination of hydroxyurea in plasma and peritoneal fluid by high-performance liquid chromatography using electrochemical detection. J Chromatogr B Biomed Sci Appl, 694, 185–91.
James, H., Nahavandi, M., Wyche, M.Q. and Taylor, R.E. (2006) Quantitative analysis of trimethylsilyl derivative of hydroxyurea in plasma by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 831, 42–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Scott, D.K., Neville, K., Garg, U. (2010). Determination of Hydroxyurea in Serum or Plasma Using Gas Chromatography-Mass Spectrometry (GC-MS). In: Garg, U., Hammett-Stabler, C. (eds) Clinical Applications of Mass Spectrometry. Methods in Molecular Biology, vol 603. Humana Press. https://doi.org/10.1007/978-1-60761-459-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-60761-459-3_26
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-458-6
Online ISBN: 978-1-60761-459-3
eBook Packages: Springer Protocols